The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Streptomycin Sulfate for Injection Market Research Report 2025
Synopsis
Streptomycin sulfate for injection has the following indications: 1. This product is mainly used in combination with other anti-tuberculosis drugs for initial treatment of various tuberculosis cases caused by Mycobacterium tuberculosis, or other sensitive mycobacterial infections. 2. This product can be used alone to treat tularemia, or in combination with other antibacterial drugs to treat plague, inguinal granuloma, brucellosis, rat-bite fever, etc. 3. It can also be combined with penicillin or ampicillin to treat endocarditis caused by viridans streptococci or enterococci.
The global Streptomycin Sulfate for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Streptomycin Sulfate for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Streptomycin Sulfate for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Streptomycin Sulfate for Injection include Metro Pharmaceuticals, Shanxi Taiyuan Pharmaceutical, North China Pharmaceutical, Wuhan Jiuan Pharmaceutical, Shenzhen Huayao Nanfang Pharmaceutical, Gansu Lanyao Pharmaceutical Co., Ltd., Henan Taifeng Biotechnology, CSPC Ouyi Pharmaceutical and Ruiyang Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Streptomycin Sulfate for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Streptomycin Sulfate for Injection.
Report Scope
The Streptomycin Sulfate for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Streptomycin Sulfate for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Streptomycin Sulfate for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Metro Pharmaceuticals
Shanxi Taiyuan Pharmaceutical
North China Pharmaceutical
Wuhan Jiuan Pharmaceutical
Shenzhen Huayao Nanfang Pharmaceutical
Gansu Lanyao Pharmaceutical Co., Ltd.
Henan Taifeng Biotechnology
CSPC Ouyi Pharmaceutical
Ruiyang Pharmaceutical
Shandong Lukang Pharmaceutical
Sinopharm Guorui Pharmaceutical
Eli Lilly and Company
PFIZER
X Gen Pharmaceuticals
Meiji Group
Segment by Type
1.0g
0.75g
Other
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Streptomycin Sulfate for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Streptomycin Sulfate for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Streptomycin sulfate for injection has the following indications: 1. This product is mainly used in combination with other anti-tuberculosis drugs for initial treatment of various tuberculosis cases caused by Mycobacterium tuberculosis, or other sensitive mycobacterial infections. 2. This product can be used alone to treat tularemia, or in combination with other antibacterial drugs to treat plague, inguinal granuloma, brucellosis, rat-bite fever, etc. 3. It can also be combined with penicillin or ampicillin to treat endocarditis caused by viridans streptococci or enterococci.
The global Streptomycin Sulfate for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Streptomycin Sulfate for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Streptomycin Sulfate for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Streptomycin Sulfate for Injection include Metro Pharmaceuticals, Shanxi Taiyuan Pharmaceutical, North China Pharmaceutical, Wuhan Jiuan Pharmaceutical, Shenzhen Huayao Nanfang Pharmaceutical, Gansu Lanyao Pharmaceutical Co., Ltd., Henan Taifeng Biotechnology, CSPC Ouyi Pharmaceutical and Ruiyang Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Streptomycin Sulfate for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Streptomycin Sulfate for Injection.
Report Scope
The Streptomycin Sulfate for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Streptomycin Sulfate for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Streptomycin Sulfate for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Metro Pharmaceuticals
Shanxi Taiyuan Pharmaceutical
North China Pharmaceutical
Wuhan Jiuan Pharmaceutical
Shenzhen Huayao Nanfang Pharmaceutical
Gansu Lanyao Pharmaceutical Co., Ltd.
Henan Taifeng Biotechnology
CSPC Ouyi Pharmaceutical
Ruiyang Pharmaceutical
Shandong Lukang Pharmaceutical
Sinopharm Guorui Pharmaceutical
Eli Lilly and Company
PFIZER
X Gen Pharmaceuticals
Meiji Group
Segment by Type
1.0g
0.75g
Other
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Streptomycin Sulfate for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Streptomycin Sulfate for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Streptomycin Sulfate for Injection Market Overview
1.1 Product Overview and Scope of Streptomycin Sulfate for Injection
1.2 Streptomycin Sulfate for Injection Segment by Type
1.2.1 Global Streptomycin Sulfate for Injection Market Value Comparison by Type (2024-2030)
1.2.2 1.0g
1.2.3 0.75g
1.2.4 Other
1.3 Streptomycin Sulfate for Injection Segment by Application
1.3.1 Global Streptomycin Sulfate for Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Streptomycin Sulfate for Injection Market Size Estimates and Forecasts
1.4.1 Global Streptomycin Sulfate for Injection Revenue 2019-2030
1.4.2 Global Streptomycin Sulfate for Injection Sales 2019-2030
1.4.3 Global Streptomycin Sulfate for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Streptomycin Sulfate for Injection Market Competition by Manufacturers
2.1 Global Streptomycin Sulfate for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Streptomycin Sulfate for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Streptomycin Sulfate for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Streptomycin Sulfate for Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Streptomycin Sulfate for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Streptomycin Sulfate for Injection, Product Type & Application
2.7 Streptomycin Sulfate for Injection Market Competitive Situation and Trends
2.7.1 Streptomycin Sulfate for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Streptomycin Sulfate for Injection Players Market Share by Revenue
2.7.3 Global Streptomycin Sulfate for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Streptomycin Sulfate for Injection Retrospective Market Scenario by Region
3.1 Global Streptomycin Sulfate for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Streptomycin Sulfate for Injection Global Streptomycin Sulfate for Injection Sales by Region: 2019-2030
3.2.1 Global Streptomycin Sulfate for Injection Sales by Region: 2019-2024
3.2.2 Global Streptomycin Sulfate for Injection Sales by Region: 2025-2030
3.3 Global Streptomycin Sulfate for Injection Global Streptomycin Sulfate for Injection Revenue by Region: 2019-2030
3.3.1 Global Streptomycin Sulfate for Injection Revenue by Region: 2019-2024
3.3.2 Global Streptomycin Sulfate for Injection Revenue by Region: 2025-2030
3.4 North America Streptomycin Sulfate for Injection Market Facts & Figures by Country
3.4.1 North America Streptomycin Sulfate for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Streptomycin Sulfate for Injection Sales by Country (2019-2030)
3.4.3 North America Streptomycin Sulfate for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Streptomycin Sulfate for Injection Market Facts & Figures by Country
3.5.1 Europe Streptomycin Sulfate for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Streptomycin Sulfate for Injection Sales by Country (2019-2030)
3.5.3 Europe Streptomycin Sulfate for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Streptomycin Sulfate for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Streptomycin Sulfate for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Streptomycin Sulfate for Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Streptomycin Sulfate for Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Streptomycin Sulfate for Injection Market Facts & Figures by Country
3.7.1 Latin America Streptomycin Sulfate for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Streptomycin Sulfate for Injection Sales by Country (2019-2030)
3.7.3 Latin America Streptomycin Sulfate for Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Streptomycin Sulfate for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Streptomycin Sulfate for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Streptomycin Sulfate for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Streptomycin Sulfate for Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Streptomycin Sulfate for Injection Sales by Type (2019-2030)
4.1.1 Global Streptomycin Sulfate for Injection Sales by Type (2019-2024)
4.1.2 Global Streptomycin Sulfate for Injection Sales by Type (2025-2030)
4.1.3 Global Streptomycin Sulfate for Injection Sales Market Share by Type (2019-2030)
4.2 Global Streptomycin Sulfate for Injection Revenue by Type (2019-2030)
4.2.1 Global Streptomycin Sulfate for Injection Revenue by Type (2019-2024)
4.2.2 Global Streptomycin Sulfate for Injection Revenue by Type (2025-2030)
4.2.3 Global Streptomycin Sulfate for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Streptomycin Sulfate for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Streptomycin Sulfate for Injection Sales by Application (2019-2030)
5.1.1 Global Streptomycin Sulfate for Injection Sales by Application (2019-2024)
5.1.2 Global Streptomycin Sulfate for Injection Sales by Application (2025-2030)
5.1.3 Global Streptomycin Sulfate for Injection Sales Market Share by Application (2019-2030)
5.2 Global Streptomycin Sulfate for Injection Revenue by Application (2019-2030)
5.2.1 Global Streptomycin Sulfate for Injection Revenue by Application (2019-2024)
5.2.2 Global Streptomycin Sulfate for Injection Revenue by Application (2025-2030)
5.2.3 Global Streptomycin Sulfate for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Streptomycin Sulfate for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Metro Pharmaceuticals
6.1.1 Metro Pharmaceuticals Corporation Information
6.1.2 Metro Pharmaceuticals Description and Business Overview
6.1.3 Metro Pharmaceuticals Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Metro Pharmaceuticals Streptomycin Sulfate for Injection Product Portfolio
6.1.5 Metro Pharmaceuticals Recent Developments/Updates
6.2 Shanxi Taiyuan Pharmaceutical
6.2.1 Shanxi Taiyuan Pharmaceutical Corporation Information
6.2.2 Shanxi Taiyuan Pharmaceutical Description and Business Overview
6.2.3 Shanxi Taiyuan Pharmaceutical Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanxi Taiyuan Pharmaceutical Streptomycin Sulfate for Injection Product Portfolio
6.2.5 Shanxi Taiyuan Pharmaceutical Recent Developments/Updates
6.3 North China Pharmaceutical
6.3.1 North China Pharmaceutical Corporation Information
6.3.2 North China Pharmaceutical Description and Business Overview
6.3.3 North China Pharmaceutical Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 North China Pharmaceutical Streptomycin Sulfate for Injection Product Portfolio
6.3.5 North China Pharmaceutical Recent Developments/Updates
6.4 Wuhan Jiuan Pharmaceutical
6.4.1 Wuhan Jiuan Pharmaceutical Corporation Information
6.4.2 Wuhan Jiuan Pharmaceutical Description and Business Overview
6.4.3 Wuhan Jiuan Pharmaceutical Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Jiuan Pharmaceutical Streptomycin Sulfate for Injection Product Portfolio
6.4.5 Wuhan Jiuan Pharmaceutical Recent Developments/Updates
6.5 Shenzhen Huayao Nanfang Pharmaceutical
6.5.1 Shenzhen Huayao Nanfang Pharmaceutical Corporation Information
6.5.2 Shenzhen Huayao Nanfang Pharmaceutical Description and Business Overview
6.5.3 Shenzhen Huayao Nanfang Pharmaceutical Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shenzhen Huayao Nanfang Pharmaceutical Streptomycin Sulfate for Injection Product Portfolio
6.5.5 Shenzhen Huayao Nanfang Pharmaceutical Recent Developments/Updates
6.6 Gansu Lanyao Pharmaceutical Co., Ltd.
6.6.1 Gansu Lanyao Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Gansu Lanyao Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Gansu Lanyao Pharmaceutical Co., Ltd. Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Gansu Lanyao Pharmaceutical Co., Ltd. Streptomycin Sulfate for Injection Product Portfolio
6.6.5 Gansu Lanyao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Henan Taifeng Biotechnology
6.6.1 Henan Taifeng Biotechnology Corporation Information
6.6.2 Henan Taifeng Biotechnology Description and Business Overview
6.6.3 Henan Taifeng Biotechnology Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Henan Taifeng Biotechnology Streptomycin Sulfate for Injection Product Portfolio
6.7.5 Henan Taifeng Biotechnology Recent Developments/Updates
6.8 CSPC Ouyi Pharmaceutical
6.8.1 CSPC Ouyi Pharmaceutical Corporation Information
6.8.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.8.3 CSPC Ouyi Pharmaceutical Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CSPC Ouyi Pharmaceutical Streptomycin Sulfate for Injection Product Portfolio
6.8.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.9 Ruiyang Pharmaceutical
6.9.1 Ruiyang Pharmaceutical Corporation Information
6.9.2 Ruiyang Pharmaceutical Description and Business Overview
6.9.3 Ruiyang Pharmaceutical Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ruiyang Pharmaceutical Streptomycin Sulfate for Injection Product Portfolio
6.9.5 Ruiyang Pharmaceutical Recent Developments/Updates
6.10 Shandong Lukang Pharmaceutical
6.10.1 Shandong Lukang Pharmaceutical Corporation Information
6.10.2 Shandong Lukang Pharmaceutical Description and Business Overview
6.10.3 Shandong Lukang Pharmaceutical Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shandong Lukang Pharmaceutical Streptomycin Sulfate for Injection Product Portfolio
6.10.5 Shandong Lukang Pharmaceutical Recent Developments/Updates
6.11 Sinopharm Guorui Pharmaceutical
6.11.1 Sinopharm Guorui Pharmaceutical Corporation Information
6.11.2 Sinopharm Guorui Pharmaceutical Streptomycin Sulfate for Injection Description and Business Overview
6.11.3 Sinopharm Guorui Pharmaceutical Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sinopharm Guorui Pharmaceutical Streptomycin Sulfate for Injection Product Portfolio
6.11.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates
6.12 Eli Lilly and Company
6.12.1 Eli Lilly and Company Corporation Information
6.12.2 Eli Lilly and Company Streptomycin Sulfate for Injection Description and Business Overview
6.12.3 Eli Lilly and Company Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Eli Lilly and Company Streptomycin Sulfate for Injection Product Portfolio
6.12.5 Eli Lilly and Company Recent Developments/Updates
6.13 PFIZER
6.13.1 PFIZER Corporation Information
6.13.2 PFIZER Streptomycin Sulfate for Injection Description and Business Overview
6.13.3 PFIZER Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 PFIZER Streptomycin Sulfate for Injection Product Portfolio
6.13.5 PFIZER Recent Developments/Updates
6.14 X Gen Pharmaceuticals
6.14.1 X Gen Pharmaceuticals Corporation Information
6.14.2 X Gen Pharmaceuticals Streptomycin Sulfate for Injection Description and Business Overview
6.14.3 X Gen Pharmaceuticals Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 X Gen Pharmaceuticals Streptomycin Sulfate for Injection Product Portfolio
6.14.5 X Gen Pharmaceuticals Recent Developments/Updates
6.15 Meiji Group
6.15.1 Meiji Group Corporation Information
6.15.2 Meiji Group Streptomycin Sulfate for Injection Description and Business Overview
6.15.3 Meiji Group Streptomycin Sulfate for Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Meiji Group Streptomycin Sulfate for Injection Product Portfolio
6.15.5 Meiji Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Streptomycin Sulfate for Injection Industry Chain Analysis
7.2 Streptomycin Sulfate for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Streptomycin Sulfate for Injection Production Mode & Process
7.4 Streptomycin Sulfate for Injection Sales and Marketing
7.4.1 Streptomycin Sulfate for Injection Sales Channels
7.4.2 Streptomycin Sulfate for Injection Distributors
7.5 Streptomycin Sulfate for Injection Customers
8 Streptomycin Sulfate for Injection Market Dynamics
8.1 Streptomycin Sulfate for Injection Industry Trends
8.2 Streptomycin Sulfate for Injection Market Drivers
8.3 Streptomycin Sulfate for Injection Market Challenges
8.4 Streptomycin Sulfate for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Streptomycin Sulfate for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Streptomycin Sulfate for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Streptomycin Sulfate for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Streptomycin Sulfate for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Streptomycin Sulfate for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Streptomycin Sulfate for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Streptomycin Sulfate for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Streptomycin Sulfate for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Streptomycin Sulfate for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Streptomycin Sulfate for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Streptomycin Sulfate for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Streptomycin Sulfate for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Streptomycin Sulfate for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Streptomycin Sulfate for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Streptomycin Sulfate for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Streptomycin Sulfate for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Streptomycin Sulfate for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Streptomycin Sulfate for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Streptomycin Sulfate for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Streptomycin Sulfate for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Streptomycin Sulfate for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Streptomycin Sulfate for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Streptomycin Sulfate for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Streptomycin Sulfate for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Streptomycin Sulfate for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Streptomycin Sulfate for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Streptomycin Sulfate for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Streptomycin Sulfate for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Streptomycin Sulfate for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Streptomycin Sulfate for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Streptomycin Sulfate for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Streptomycin Sulfate for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Streptomycin Sulfate for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Streptomycin Sulfate for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Streptomycin Sulfate for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Streptomycin Sulfate for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Streptomycin Sulfate for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Streptomycin Sulfate for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Streptomycin Sulfate for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Streptomycin Sulfate for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Streptomycin Sulfate for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Streptomycin Sulfate for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Streptomycin Sulfate for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Streptomycin Sulfate for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Streptomycin Sulfate for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Streptomycin Sulfate for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Streptomycin Sulfate for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Streptomycin Sulfate for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Streptomycin Sulfate for Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Streptomycin Sulfate for Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Streptomycin Sulfate for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Streptomycin Sulfate for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Streptomycin Sulfate for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Streptomycin Sulfate for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Streptomycin Sulfate for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Streptomycin Sulfate for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Streptomycin Sulfate for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Streptomycin Sulfate for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Streptomycin Sulfate for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Streptomycin Sulfate for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Streptomycin Sulfate for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Streptomycin Sulfate for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Streptomycin Sulfate for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Streptomycin Sulfate for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Streptomycin Sulfate for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Streptomycin Sulfate for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Streptomycin Sulfate for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Streptomycin Sulfate for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Metro Pharmaceuticals Corporation Information
Table 71. Metro Pharmaceuticals Description and Business Overview
Table 72. Metro Pharmaceuticals Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Metro Pharmaceuticals Streptomycin Sulfate for Injection Product
Table 74. Metro Pharmaceuticals Recent Developments/Updates
Table 75. Shanxi Taiyuan Pharmaceutical Corporation Information
Table 76. Shanxi Taiyuan Pharmaceutical Description and Business Overview
Table 77. Shanxi Taiyuan Pharmaceutical Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Shanxi Taiyuan Pharmaceutical Streptomycin Sulfate for Injection Product
Table 79. Shanxi Taiyuan Pharmaceutical Recent Developments/Updates
Table 80. North China Pharmaceutical Corporation Information
Table 81. North China Pharmaceutical Description and Business Overview
Table 82. North China Pharmaceutical Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. North China Pharmaceutical Streptomycin Sulfate for Injection Product
Table 84. North China Pharmaceutical Recent Developments/Updates
Table 85. Wuhan Jiuan Pharmaceutical Corporation Information
Table 86. Wuhan Jiuan Pharmaceutical Description and Business Overview
Table 87. Wuhan Jiuan Pharmaceutical Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Wuhan Jiuan Pharmaceutical Streptomycin Sulfate for Injection Product
Table 89. Wuhan Jiuan Pharmaceutical Recent Developments/Updates
Table 90. Shenzhen Huayao Nanfang Pharmaceutical Corporation Information
Table 91. Shenzhen Huayao Nanfang Pharmaceutical Description and Business Overview
Table 92. Shenzhen Huayao Nanfang Pharmaceutical Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Shenzhen Huayao Nanfang Pharmaceutical Streptomycin Sulfate for Injection Product
Table 94. Shenzhen Huayao Nanfang Pharmaceutical Recent Developments/Updates
Table 95. Gansu Lanyao Pharmaceutical Co., Ltd. Corporation Information
Table 96. Gansu Lanyao Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Gansu Lanyao Pharmaceutical Co., Ltd. Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Gansu Lanyao Pharmaceutical Co., Ltd. Streptomycin Sulfate for Injection Product
Table 99. Gansu Lanyao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Henan Taifeng Biotechnology Corporation Information
Table 101. Henan Taifeng Biotechnology Description and Business Overview
Table 102. Henan Taifeng Biotechnology Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Henan Taifeng Biotechnology Streptomycin Sulfate for Injection Product
Table 104. Henan Taifeng Biotechnology Recent Developments/Updates
Table 105. CSPC Ouyi Pharmaceutical Corporation Information
Table 106. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 107. CSPC Ouyi Pharmaceutical Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CSPC Ouyi Pharmaceutical Streptomycin Sulfate for Injection Product
Table 109. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 110. Ruiyang Pharmaceutical Corporation Information
Table 111. Ruiyang Pharmaceutical Description and Business Overview
Table 112. Ruiyang Pharmaceutical Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Ruiyang Pharmaceutical Streptomycin Sulfate for Injection Product
Table 114. Ruiyang Pharmaceutical Recent Developments/Updates
Table 115. Shandong Lukang Pharmaceutical Corporation Information
Table 116. Shandong Lukang Pharmaceutical Description and Business Overview
Table 117. Shandong Lukang Pharmaceutical Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Shandong Lukang Pharmaceutical Streptomycin Sulfate for Injection Product
Table 119. Shandong Lukang Pharmaceutical Recent Developments/Updates
Table 120. Sinopharm Guorui Pharmaceutical Corporation Information
Table 121. Sinopharm Guorui Pharmaceutical Description and Business Overview
Table 122. Sinopharm Guorui Pharmaceutical Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Sinopharm Guorui Pharmaceutical Streptomycin Sulfate for Injection Product
Table 124. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
Table 125. Eli Lilly and Company Corporation Information
Table 126. Eli Lilly and Company Description and Business Overview
Table 127. Eli Lilly and Company Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Eli Lilly and Company Streptomycin Sulfate for Injection Product
Table 129. Eli Lilly and Company Recent Developments/Updates
Table 130. PFIZER Corporation Information
Table 131. PFIZER Description and Business Overview
Table 132. PFIZER Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. PFIZER Streptomycin Sulfate for Injection Product
Table 134. PFIZER Recent Developments/Updates
Table 135. X Gen Pharmaceuticals Corporation Information
Table 136. X Gen Pharmaceuticals Description and Business Overview
Table 137. X Gen Pharmaceuticals Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. X Gen Pharmaceuticals Streptomycin Sulfate for Injection Product
Table 139. X Gen Pharmaceuticals Recent Developments/Updates
Table 140. Meiji Group Corporation Information
Table 141. Meiji Group Description and Business Overview
Table 142. Meiji Group Streptomycin Sulfate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Meiji Group Streptomycin Sulfate for Injection Product
Table 144. Meiji Group Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Streptomycin Sulfate for Injection Distributors List
Table 148. Streptomycin Sulfate for Injection Customers List
Table 149. Streptomycin Sulfate for Injection Market Trends
Table 150. Streptomycin Sulfate for Injection Market Drivers
Table 151. Streptomycin Sulfate for Injection Market Challenges
Table 152. Streptomycin Sulfate for Injection Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Streptomycin Sulfate for Injection
Figure 2. Global Streptomycin Sulfate for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Streptomycin Sulfate for Injection Market Share by Type in 2023 & 2030
Figure 4. 1.0g Product Picture
Figure 5. 0.75g Product Picture
Figure 6. Other Product Picture
Figure 7. Global Streptomycin Sulfate for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Streptomycin Sulfate for Injection Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Streptomycin Sulfate for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Streptomycin Sulfate for Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Streptomycin Sulfate for Injection Sales (2019-2030) & (K Units)
Figure 14. Global Streptomycin Sulfate for Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Streptomycin Sulfate for Injection Report Years Considered
Figure 16. Streptomycin Sulfate for Injection Sales Share by Manufacturers in 2023
Figure 17. Global Streptomycin Sulfate for Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Streptomycin Sulfate for Injection Players: Market Share by Revenue in 2023
Figure 19. Streptomycin Sulfate for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Streptomycin Sulfate for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Streptomycin Sulfate for Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Streptomycin Sulfate for Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Streptomycin Sulfate for Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Streptomycin Sulfate for Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Netherlands Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Streptomycin Sulfate for Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Streptomycin Sulfate for Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Streptomycin Sulfate for Injection Sales Market Share by Country (2019-2030)
Figure 42. Latin America Streptomycin Sulfate for Injection Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Streptomycin Sulfate for Injection Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Streptomycin Sulfate for Injection Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Streptomycin Sulfate for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Streptomycin Sulfate for Injection by Type (2019-2030)
Figure 52. Global Revenue Market Share of Streptomycin Sulfate for Injection by Type (2019-2030)
Figure 53. Global Streptomycin Sulfate for Injection Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Streptomycin Sulfate for Injection by Application (2019-2030)
Figure 55. Global Revenue Market Share of Streptomycin Sulfate for Injection by Application (2019-2030)
Figure 56. Global Streptomycin Sulfate for Injection Price (US$/Unit) by Application (2019-2030)
Figure 57. Streptomycin Sulfate for Injection Value Chain
Figure 58. Streptomycin Sulfate for Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
